Results 11 to 20 of about 101,057 (247)

Vaccine adjuvants: mechanisms and platforms

open access: yesSignal Transduction and Targeted Therapy, 2023
Adjuvants are indispensable components of vaccines. Despite being widely used in vaccines, their action mechanisms are not yet clear. With a greater understanding of the mechanisms by which the innate immune response controls the antigen-specific ...
Tingmei Zhao   +6 more
doaj   +2 more sources

Vaccine Potentiation by Combination Adjuvants

open access: yesVaccines, 2014
Adjuvants are crucial components of vaccines. They significantly improve vaccine efficacy by modulating, enhancing, or extending the immune response and at the same time reducing the amount of antigen needed. In contrast to previously licensed adjuvants,
Benoît Levast   +5 more
doaj   +2 more sources

Adjuvants : an essential component of neisseria vaccines [PDF]

open access: yes, 2009
Adjuvants may be classified into delivery systems and immune potentiator or modulator molecules based on their mechanism of action. Neisseria vaccines containing traditional adjuvants such as aluminium salts have existed for long time, but meningitis ...
Acevedo, R.   +8 more
core   +4 more sources

Vaccines with adjuvants. Preclinical studies [PDF]

open access: yesБиопрепараты: Профилактика, диагностика, лечение, 2018
The paper presents the data on safety and efficacy assessment of adjuvants and vaccines with adjuvants at the stages of development and preclinical studies based on international recommendations.
Zh. I. Avdeeva   +10 more
doaj   +1 more source

Adjuvants

open access: yes, 1998
Australasian Biotechnology, Volume 8 Number 3, May/June 1998, pp. 148-152 Adjuvants John C Cox, Code Number:AU98022 Sizes of Files: Text: 21K Graphics: Line drawings (gif) - 9K Adjuvants can act in a number of diverse ways to help the immune ...

core   +8 more sources

Antibiotic adjuvants: synergistic tool to combat multi-drug resistant pathogens

open access: yesFrontiers in Cellular and Infection Microbiology, 2023
The rise of multi-drug resistant (MDR) pathogens poses a significant challenge to the field of infectious disease treatment. To overcome this problem, novel strategies are being explored to enhance the effectiveness of antibiotics.
Vikram Kumar   +10 more
doaj   +1 more source

Vaccine containing immunologic adjuvants with a wide range of activity to provide protection against COVID-19 [PDF]

open access: yes, 2021
COVID-19 is a devastating viral disease which can be prevented by vaccination. Immunologic adjuvants are key to develop an effective vaccines against infectious diseases in human and non-human primates.
Berhanu, Mulugeta
core   +1 more source

New-age vaccine adjuvants, their development, and future perspective

open access: yesFrontiers in Immunology, 2023
In the present scenario, immunization is of utmost importance as it keeps us safe and protects us from infectious agents. Despite the great success in the field of vaccinology, there is a need to not only develop safe and ideal vaccines to fight deadly ...
Shailendra Kumar Verma   +6 more
doaj   +1 more source

Immune mechanisms of protection: can adjuvants rise to the challenge? [PDF]

open access: yes, 2010
For many diseases vaccines are lacking or only partly effective. Research on protective immunity and adjuvants that generate vigorous immune responses may help generate effective vaccines against such ...
MacLeod Megan KL   +11 more
core   +1 more source

A Universally Primed-Polymerase Chain Reaction (UP-PCR) Marker to Discriminate Clonostachys rosea ACM941 from Related Strains

open access: yesJournal of Fungi, 2019
Clonostachys rosea strain ACM941 is an effective biocontrol agent against several crop diseases including Fusarium head blight. In anticipation of its increased relevance going forward, the development of a reliable DNA-based molecular marker to track it
Zerihun A. Demissie   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy